Phase 3 Trial Demonstrates Superior Patient Treatment Convenience of MC2-01 Calcipotriene Plus Betamethasone Dipropionate Cream Compared to Current Topical Suspension. (2020). SKIN The Journal of Cutaneous Medicine, 4(5), s62. https://doi.org/10.25251/skin.4.supp.61